arrow
D

David Ghez

Gustave Roussy Institute
H指数:26
被引数:2,800

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cerebral aspergillosis under ibrutinib therapy: clinical features and management challenges

伊布替尼治疗下的脑曲霉菌病:临床特征与管理挑战

2026-08-040
PRE
The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infection

嘌呤能受体P2X7和NLRP3炎性体是SARS-CoV-2感染所需的可药物宿主因子

2023-10-187
OAAI
Favorable pharmacokinetic and pharmacodynamic properties of gilteritinib in cerebrospinal fluid: a potential effective treatment in relapsing meningeal acute myeloid leukemia FLT3-ITD patients
2023-02-165
OAAI
Sequence analyses of relapsed or refractory diffuse large B-cell lymphomas unravel three genetic subgroups of patients and the GNA13 mutant as poor prognostic biomarker, results of LNH-EP1 study
2023-01-181
OAAI
Retrospective analysis of a cohort of 41 de novo B-cell prolymphocytic leukemia patients: impact of genetics and targeted therapies (a FILO study)
2022-12-224
OAAI
Therapy-related Myeloid Neoplasms in Patients With Chronic Lymphocytic Leukemia Who Received FCR/FC as Frontline Therapy
2022-06-012
OAAI
Innovative therapies based on molecular orientation in patients with relapse and refractory diffuse large B-cell lymphoma: Results of LNH-EP1 study
2021-07-102
OAAI
Diagnosis and Treatment of Chronic Lymphocytic Leukemia: Recommendations of the French CLL Study Group (FILO)
2020-09-2325
OAAI
Ibrutinib and idelalisib in the management of CLL-associated autoimmune cytopenias: a study from the FILO group
2019-04-1119
OAAI